Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1921 to 1926 of 1926 entries
Sorted by: Best Match Show Resources per page
Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides.

Environmental science and pollution research international

Gomaa OM, Jassim AY, Chanda A.
PMID: 35001269
Environ Sci Pollut Res Int. 2022 Jan 10; doi: 10.1007/s11356-021-18018-9. Epub 2022 Jan 10.

Extensive use of engineered nanoparticles has led to their eventual release in the environment. The present work aims to study the removal of Polyvinylpyrrolidone-coated silver nanoparticles (PVP-Ag-NPs) using Aspergillus niger and depict the role of exopolysaccharides in the removal...

Cite
Gomaa OM, Jassim AY, Chanda A. Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides. Environ Sci Pollut Res Int. 2022;doi: 10.1007/s11356-021-18018-9.
Gomaa, O. M., Jassim, A. Y., & Chanda, A. (2022). Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides. Environmental science and pollution research international, . https://doi.org/10.1007/s11356-021-18018-9
Gomaa, Ola M, et al. "Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides." Environmental science and pollution research international vol. (2022). doi: https://doi.org/10.1007/s11356-021-18018-9
Gomaa OM, Jassim AY, Chanda A. Bioremoval of PVP-coated silver nanoparticles using Aspergillus niger: the role of exopolysaccharides. Environ Sci Pollut Res Int. 2022 Jan 10; doi: 10.1007/s11356-021-18018-9. Epub 2022 Jan 10. PMID: 35001269; PMCID: PMC8743098.
Copy Download .nbib Format: NLM
Structure of a consensus chitin-binding domain revealed by solution NMR.

Journal of structural biology

Heymann D, Mohanram H, Kumar A, Verma CS, Lescar J, Miserez A.
PMID: 33744410
J Struct Biol. 2021 Jun;213(2):107725. doi: 10.1016/j.jsb.2021.107725. Epub 2021 Mar 18.

Chitin-binding proteins (CBPs) are a versatile group of proteins found in almost every organism on earth. CBPs are involved in enzymatic carbohydrate degradation and also serve as templating scaffolds in the exoskeleton of crustaceans and insects. One specific chitin-binding...

Cite
Heymann D, Mohanram H, Kumar A, et al. Structure of a consensus chitin-binding domain revealed by solution NMR. J Struct Biol. 2021;213(2):107725doi: 10.1016/j.jsb.2021.107725.
Heymann, D., Mohanram, H., Kumar, A., Verma, C. S., Lescar, J., & Miserez, A. (2021). Structure of a consensus chitin-binding domain revealed by solution NMR. Journal of structural biology, 213(2), 107725. https://doi.org/10.1016/j.jsb.2021.107725
Heymann, Dario, et al. "Structure of a consensus chitin-binding domain revealed by solution NMR." Journal of structural biology vol. 213,2 (2021): 107725. doi: https://doi.org/10.1016/j.jsb.2021.107725
Heymann D, Mohanram H, Kumar A, Verma CS, Lescar J, Miserez A. Structure of a consensus chitin-binding domain revealed by solution NMR. J Struct Biol. 2021 Jun;213(2):107725. doi: 10.1016/j.jsb.2021.107725. Epub 2021 Mar 18. PMID: 33744410.
Copy Download .nbib Format: NLM
Collaboration Between Tele-ICU Programs Has the Potential to Rapidly Increase the Availability of Critical Care Physicians-Our Experience Was During Coronavirus Disease 2019 Nomenclature.

Critical care explorations

Chandra S, Hertz C, Khurana H, Doerfler ME.
PMID: 33786439
Crit Care Explor. 2021 Mar 05;3(3):e0363. doi: 10.1097/CCE.0000000000000363. eCollection 2021 Mar.

OBJECTIVES: Implement a connected network between two Tele-ICU programs to support staffing and rounding during the first wave of the coronavirus disease 2019 pandemic in the United States.DESIGN: Proof of Concept model.SETTING: Northwell Health; a 23 Hospital, 40 ICU...

Cite
Chandra S, Hertz C, Khurana H, et al. Collaboration Between Tele-ICU Programs Has the Potential to Rapidly Increase the Availability of Critical Care Physicians-Our Experience Was During Coronavirus Disease 2019 Nomenclature. Crit Care Explor. 2021;3(3):e0363doi: 10.1097/CCE.0000000000000363.
Chandra, S., Hertz, C., Khurana, H., & Doerfler, M. E. (2021). Collaboration Between Tele-ICU Programs Has the Potential to Rapidly Increase the Availability of Critical Care Physicians-Our Experience Was During Coronavirus Disease 2019 Nomenclature. Critical care explorations, 3(3), e0363. https://doi.org/10.1097/CCE.0000000000000363
Chandra, Saurabh, et al. "Collaboration Between Tele-ICU Programs Has the Potential to Rapidly Increase the Availability of Critical Care Physicians-Our Experience Was During Coronavirus Disease 2019 Nomenclature." Critical care explorations vol. 3,3 (2021): e0363. doi: https://doi.org/10.1097/CCE.0000000000000363
Chandra S, Hertz C, Khurana H, Doerfler ME. Collaboration Between Tele-ICU Programs Has the Potential to Rapidly Increase the Availability of Critical Care Physicians-Our Experience Was During Coronavirus Disease 2019 Nomenclature. Crit Care Explor. 2021 Mar 05;3(3):e0363. doi: 10.1097/CCE.0000000000000363. eCollection 2021 Mar. PMID: 33786439; PMCID: PMC7994031.
Copy Download .nbib Format: NLM
Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma.

Nature communications

Ribas A, Algazi A, Ascierto PA, Butler MO, Chandra S, Gordon M, Hernandez-Aya L, Lawrence D, Lutzky J, Miller WH, Campbell KM, Delafont B, Marshall S, Mueller N, Robert C.
PMID: 34385448
Nat Commun. 2021 Aug 12;12(1):5022. doi: 10.1038/s41467-021-25285-0.

No abstract available.

Cite
Ribas A, Algazi A, Ascierto PA, et al. Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nat Commun. 2021;12(1):5022doi: 10.1038/s41467-021-25285-0.
Ribas, A., Algazi, A., Ascierto, P. A., Butler, M. O., Chandra, S., Gordon, M., Hernandez-Aya, L., Lawrence, D., Lutzky, J., Miller, W. H., Campbell, K. M., Delafont, B., Marshall, S., Mueller, N., & Robert, C. (2021). Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nature communications, 12(1), 5022. https://doi.org/10.1038/s41467-021-25285-0
Ribas, Antoni, et al. "Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma." Nature communications vol. 12,1 (2021): 5022. doi: https://doi.org/10.1038/s41467-021-25285-0
Ribas A, Algazi A, Ascierto PA, Butler MO, Chandra S, Gordon M, Hernandez-Aya L, Lawrence D, Lutzky J, Miller WH, Campbell KM, Delafont B, Marshall S, Mueller N, Robert C. Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nat Commun. 2021 Aug 12;12(1):5022. doi: 10.1038/s41467-021-25285-0. PMID: 34385448; PMCID: PMC8360951.
Copy Download .nbib Format: NLM
Src activates retrograde membrane traffic through phosphorylation of GBF1.

eLife

Chia J, Wang SC, Wee S, Gill DJ, Tay F, Kannan S, Verma CS, Gunaratne J, Bard FA.
PMID: 34870592
Elife. 2021 Dec 06;10. doi: 10.7554/eLife.68678.

The Src tyrosine kinase controls cancer-critical protein glycosylation through Golgi to ER relocation of GALNTs enzymes. How Src induces this trafficking event is unknown. Golgi to ER transport depends on the GTP exchange factor (GEF) GBF1 and small GTPase...

Cite
Chia J, Wang SC, Wee S, et al. Src activates retrograde membrane traffic through phosphorylation of GBF1. Elife. 2021;10doi: 10.7554/eLife.68678.
Chia, J., Wang, S. C., Wee, S., Gill, D. J., Tay, F., Kannan, S., Verma, C. S., Gunaratne, J., & Bard, F. A. (2021). Src activates retrograde membrane traffic through phosphorylation of GBF1. eLife, 10. https://doi.org/10.7554/eLife.68678
Chia, Joanne, et al. "Src activates retrograde membrane traffic through phosphorylation of GBF1." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.68678
Chia J, Wang SC, Wee S, Gill DJ, Tay F, Kannan S, Verma CS, Gunaratne J, Bard FA. Src activates retrograde membrane traffic through phosphorylation of GBF1. Elife. 2021 Dec 06;10. doi: 10.7554/eLife.68678. PMID: 34870592.
Copy Download .nbib Format: NLM
Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults.

Transplantation

Wang YM, Teusink-Cross A, Elborai Y, Krupski MC, Nelson AS, Grimley MS, Flannery A, Mehta PA, Bleesing JJ, Chandra S, Kumar AR, Myers KC, Davies SM, Khandelwal P.
PMID: 33795598
Transplantation. 2021 Mar 26; doi: 10.1097/TP.0000000000003768. Epub 2021 Mar 26.

BACKGROUND: Ruxolitinib, a JAK1/2 inhibitor, is used to treat chronic graft-versus-host-disease (cGVHD) in adult allogeneic hematopoietic stem cell transplant patients, but experience in children is limited, perhaps due to lack of pediatric dosing information. In this report we describe...

Cite
Wang YM, Teusink-Cross A, Elborai Y, et al. Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults. Transplantation. 2021;doi: 10.1097/TP.0000000000003768.
Wang, Y. M., Teusink-Cross, A., Elborai, Y., Krupski, M. C., Nelson, A. S., Grimley, M. S., Flannery, A., Mehta, P. A., Bleesing, J. J., Chandra, S., Kumar, A. R., Myers, K. C., Davies, S. M., & Khandelwal, P. (2021). Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults. Transplantation, . https://doi.org/10.1097/TP.0000000000003768
Wang, YunZu Michele, et al. "Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults." Transplantation vol. (2021). doi: https://doi.org/10.1097/TP.0000000000003768
Wang YM, Teusink-Cross A, Elborai Y, Krupski MC, Nelson AS, Grimley MS, Flannery A, Mehta PA, Bleesing JJ, Chandra S, Kumar AR, Myers KC, Davies SM, Khandelwal P. Ruxolitinib for the treatment of chronic GVHD and overlap syndrome in children and young adults. Transplantation. 2021 Mar 26; doi: 10.1097/TP.0000000000003768. Epub 2021 Mar 26. PMID: 33795598.
Copy Download .nbib Format: NLM
Showing 1921 to 1926 of 1926 entries